Journal of Hematology and Oncology Research

Aims and Scope

Open Access Pub launches the Open Peer Reviewed Journal -” Journal of Hematology and Oncology Research ISSN NO: 2372-6601”. The journal aims to cover the latest outstanding developments in Hematology and Oncology. 

The Journal of Hematology and Oncology Research is a scientific journal that aims to advance the understanding of hematological and oncological conditions and their treatments. JHOR publishes high-quality research that covers a wide range of topics, including blood disorders, cancer care i.e. diagnosis and treatment, and immunology, Gynecologic Oncology, Radiation Oncology, Oral Oncology, Molecular Oncology, Cellular Oncology, Pediatric Hematology and Pediatric Oncology, Surgical Oncology, Neuro Oncology.

The scope of JHOR includes, but is not limited to, the following topics:

1. Blood Disorders: Submissions welcome on anemia, bleeding disorders, blood clots, blood cancers (leukemia, lymphoma), and white blood cell and platelet disorders.
2. Cancer Diagnosis and Treatment: Interested in articles covering cancer diagnosis, treatment, and management, including novel techniques, surgery, chemotherapy, radiation therapy, and targeted therapies.
3. Immunology: Publishes research on the immune system's role in hematological and oncological conditions, including immune-mediated diseases, dysfunction, and immune-based therapies.
4. Hematological and Oncological Conditions: Covers blood cancers, solid tumors, diagnostic and therapeutic approaches, research on pathogenesis, clinical trials, safety and effectiveness of treatments, health services research, and psychosocial issues in patients and caregivers.

Contributions from the following research areas are invited but not limited to the following branches:
 

Cancer Types:

• Skin cancer
• Breast cancer
• Cervical cancer
• Lung cancer
• Ovarian cancer
• Endometrial cancer
• Uterine cancer
• Vulvar cancer
• Head and neck cancer
• Acute myeloid leukemia
• B-Cell-lymphoma
• Vaginal cancer
• Fallopian tube cancer
• Gastrointestinal cancer
• Germ cell tumors
• Hematologic malignancies
• Genitourinary cancer
• Neuro-oncology
• Thoracic cancer
• Solid tumors
• Germ cell tumors
• Neurosurgical oncology
• Ocular oncology
• Genitourinary cancer
• Neurooncology
• Allergo oncology
• Aids and gynecologic cancers
• Epithelial ovarian cancer and primary peritoneal cancer
• Malignant ovarian germ cell tumors
• Mixed müllerian tumor

Medical Specialties:

• Oncology
• Hematology
• Hematopoiesis
• Hematopoietic stem cell transplantation
• Hematological malignancies
• Pediatric oncology
• Medical oncology
• Surgical oncology
• Radiation oncology
• Gynecologic oncology
• Urologic oncology
• Interventional oncology
• Hematology-oncology
• Clinical neuro-oncology
• Science of blood transfusion
• Stem cells and hematopoiesis

Treatment and Therapies:

• Palliative care
• Chemotherapy
• Immunotherapy
• Blood-transfusion
• Radiation oncology
• Pharmacogenetics
• Cancer vaccines
• Drug design
• Hematopoietic cell
• Chemoresistance
• Blood and marrow transplantation
• Drug design and development
• Tumor sensitization
• Nonsurgical tumor ablation
• Recent developments in tumor therapy
• Molecular diagnostics and targeted cancer therapies

Biological Processes and Mechanisms:

• Epigenetics
• Hematopoiesis
• Leukocytes
• Platelets
• Genetics
• Signal transduction
• Cytogenetics
• Tumor microenvironment
• Tumor markers
• Hemolytic anemias
• Hemorrhagic disorders
• Hematologic neoplasia
• Gene Transfer for Anemia
• Genetics of immune function
• Sickle cell disorders
• Platelets in thrombosis
• Red and white blood cell disorders
• Sex cord stromal tumors
• Molecular oncology
• Leukemogenesis
• Cancer immunology
• Cancer genomics
• Cancer imaging
• Cancer stem cell biology
• Tumor surveillance
• Blood protein disorders
• Genetics and hereditary cancer
• Molecular diagnostics and targeted cancer therapies

Medical Procedures and Practices:

• Blood group incompatibility
• Blood coagulation disorders
• Blood platelet disorders
• Blood protein disorders
• Common blood cancers
• Hematologic pregnancy complications
• Recent developments in tumor therapy
• General hematology
• Tumor surveillance
• Blood and marrow transplantation
• Cancer in pregnancy
• Stem cells and hematopoiesis

JHOR welcomes diverse submissions from global researchers and clinicians, emphasizing scientific rigor and clinical relevance. Journal aims to facilitate the exchange of ideas and information in hematology and oncology, promoting high-quality research to advance knowledge and improve patient care. JHOR goal is to make a significant impact on patients' lives by enhancing understanding of conditions and treatments, leading to better diagnostic and therapeutic approaches and improved outcomes.